GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 282 filers reported holding GUARDANT HEALTH INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,570,706 | +1873.6% | 795,233 | +2283.8% | 0.05% | +1500.0% |
| Q2 2023 | $1,194,288 | -96.7% | 33,360 | -97.9% | 0.00% | -96.7% |
| Q1 2023 | $36,683,155 | +22.4% | 1,564,981 | +42.0% | 0.09% | +12.2% |
| Q4 2022 | $29,968,906 | +35.0% | 1,101,798 | +167.1% | 0.08% | +20.6% |
| Q3 2022 | $22,203,000 | +11.9% | 412,462 | -16.1% | 0.07% | +6.2% |
| Q2 2022 | $19,838,000 | -74.2% | 491,760 | -57.6% | 0.06% | -73.7% |
| Q1 2022 | $76,872,000 | +56.8% | 1,160,509 | +136.8% | 0.24% | +44.6% |
| Q4 2021 | $49,028,000 | +45.7% | 490,182 | +80.9% | 0.17% | +5.7% |
| Q2 2021 | $33,649,000 | +37.4% | 270,947 | +42.6% | 0.16% | +16.9% |
| Q4 2020 | $24,490,000 | +457.6% | 190,022 | +383.7% | 0.14% | +325.0% |
| Q3 2020 | $4,392,000 | +109.1% | 39,288 | +51.8% | 0.03% | +77.8% |
| Q2 2020 | $2,100,000 | – | 25,882 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |